BACKTelomere lengths can serve as useful clinical biomarkers. Several of us have suggested this point since the mid 1990’s and my 2012 article on this potential (Use of telomere length as a biomarker for aging and age-related disease) clarified the pro’s and con’s of this area. More recently (February 2013), an article in JAMA showed […]
Telomeres as biomarkers
Telomere lengths can serve as useful clinical biomarkers. Several of us have suggested this point since the mid 1990’s and my 2012 article on this potential (Use of telomere length as a biomarker for aging and age-related disease) clarified the pro’s and con’s of this area. More recently (February 2013), an article in JAMA showed that telomere lengths serve as a biomarker for immune responses, specifically to URI’s in human patients.
- Aging diseases (58)
- Alzheimer's disease (55)
- Big Pharma (3)
- Biotech (11)
- BioViva (3)
- Book (1)
- Cancer (2)
- Dementia (1)
- Epigenetics (20)
- microglia (13)
- mitochondria (13)
- monoclonal antibodies (2)
- Osteoarthritis (10)
- Osteoporosis (7)
- progeria (6)
- senescent cells (24)
- solanezumab (5)
- Telocyte (16)
- Telomerase (26)
- Telomeres (29)
- The Telomerase Revolution (11)